Eigen Therapeutics Eigen Therapeutics is a biotechnology company that develops therapeutics for cancer. | ![]() Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | ![]() Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. | ![]() Eleven Tx Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics. | ||
Founding Date | Founding Date 2021 | Founding Date 2015 | Founding Date 2022 | Founding Date 2003 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations Redwood City, US HQ | Locations San Mateo, US HQ | Locations Haifa, IL HQ Potsdam, DE | Locations Tel Aviv-Yafo, IL HQ Cambridge, GB Boston, US |
Employees | Employees 10 | Employees 5248% decrease | Employees 40 | Employees 106 | Employees 29 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 25.6 m | Valuation ($) N/A | Valuation ($) 25.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1.3m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($33.4m) (FY, 2025) | Net income N/A | Net income ($23.3m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 7m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 3 years ago) | Latest funding round N/A | Latest funding round $ 22m (almost 4 years ago) |
Total funding raised | Total funding raised $ 7m | Total funding raised $ 177.5m | Total funding raised $ 50m | Total funding raised $ 78.4m | Total funding raised $ 22m |

Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company
EpiBiologics is a company that provides a protein degradation platform.
View company
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
View company
Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.
View company